Omniscan
Omniscan is a contrast agent used primarily in medical imaging to enhance the visibility of internal structures during certain diagnostic procedures. It belongs to the class of gadolinium-based contrast agents (GBCAs), which are commonly employed in magnetic resonance imaging (MRI) scans. The active ingredient in Omniscan is gadodiamide, a paramagnetic compound that shortens the relaxation times of nearby hydrogen protons, thereby improving the contrast between different tissues and fluids in MRI images.
Developed by GE Healthcare, Omniscan is approved for use in various MRI applications, including the evaluation
Omniscan is available in a sterile, aqueous solution and is administered under medical supervision. Its use
Clinical guidelines recommend minimizing unnecessary use of GBCAs and adhering to the lowest effective dose to